State Street Corporation 13D and 13G filings for Iovance Biotherapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-10-18 08:38 am Sale |
2024-09-30 | 13G | Iovance Biotherapeutics, Inc. IOVA |
STATE STREET CORP STT |
13,201,978 4.400% |
-3,222,410 (-19.62%) |
Filing |
| 2024-01-25 10:49 am Purchase |
2023-12-31 | 13G | Iovance Biotherapeutics, Inc. IOVA |
STATE STREET CORP STT |
16,424,388 6.420% |
1,708,913 (+11.61%) |
Filing |
| 2023-02-02 12:29 pm Purchase |
2022-12-31 | 13G | Iovance Biotherapeutics, Inc. IOVA |
STATE STREET CORP STT |
14,715,475 9.320% |
14,715,475 (New Position) |
Filing |